Approvals/TGA/DEPROCIP medroxyprogesterone acetate 150 mg/1 mL injection suspension vial

Approved

STANDARD

DEPROCIP medroxyprogesterone acetate 150 mg/1 mL injection suspension vial

Cipla Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 3c785a6286b863e1
Product Name: DEPROCIP medroxyprogesterone acetate 150 mg/1 mL injection suspension vial
Artg Id: 318838
Artg Name: DEPROCIP medroxyprogesterone acetate 150 mg/1 mL injection suspension vial
Sponsor: Cipla Australia Pty Ltd
Company Detail Path: /organization/cipla-australia-pty-ltd
Artg Date: 2020-05-13
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

3c785a6286b863e1

Type

Standard